News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Elixir Medical Corporation To Showcase A Live Case Demonstration Of The Breakthrough Fully Bioresorbable DESolveĀ® 100 Novolimus Eluting Coronary Scaffold System At EuroPCR


5/14/2014 7:39:50 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it will showcase a live case demonstration of its breakthrough DESolveĀ® 100 Novolimus Eluting Bioresorbable Coronary Scaffold System at EuroPCR in Paris on Tuesday, May 20th 2014. EuroPCR is the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES